Aurora Cannabis (ACB) Competitors $5.52 +0.15 (+2.70%) As of 11:44 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ACB vs. CALT, OCUL, AMPH, AUPH, MLYS, RCUS, ARDX, NTLA, PAHC, and COLLShould you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Calliditas Therapeutics AB (publ) (CALT), Ocular Therapeutix (OCUL), Amphastar Pharmaceuticals (AMPH), Aurinia Pharmaceuticals (AUPH), Mineralys Therapeutics (MLYS), Arcus Biosciences (RCUS), Ardelyx (ARDX), Intellia Therapeutics (NTLA), Phibro Animal Health (PAHC), and Collegium Pharmaceutical (COLL). These companies are all part of the "pharmaceutical products" industry. Aurora Cannabis vs. Calliditas Therapeutics AB (publ) Ocular Therapeutix Amphastar Pharmaceuticals Aurinia Pharmaceuticals Mineralys Therapeutics Arcus Biosciences Ardelyx Intellia Therapeutics Phibro Animal Health Collegium Pharmaceutical Calliditas Therapeutics AB (publ) (NASDAQ:CALT) and Aurora Cannabis (NASDAQ:ACB) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends, profitability and community ranking. Does the MarketBeat Community believe in CALT or ACB? Aurora Cannabis received 357 more outperform votes than Calliditas Therapeutics AB (publ) when rated by MarketBeat users. Likewise, 59.63% of users gave Aurora Cannabis an outperform vote while only 55.10% of users gave Calliditas Therapeutics AB (publ) an outperform vote. CompanyUnderperformOutperformCalliditas Therapeutics AB (publ)Outperform Votes2755.10% Underperform Votes2244.90% Aurora CannabisOutperform Votes38459.63% Underperform Votes26040.37% Which has preferable earnings & valuation, CALT or ACB? Calliditas Therapeutics AB (publ) has higher revenue and earnings than Aurora Cannabis. Calliditas Therapeutics AB (publ) is trading at a lower price-to-earnings ratio than Aurora Cannabis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCalliditas Therapeutics AB (publ)$1.60B0.74-$43.96M-$1.85-21.62Aurora Cannabis$320.81M0.97-$48.62M$0.05110.30 Is CALT or ACB more profitable? Aurora Cannabis has a net margin of 0.42% compared to Calliditas Therapeutics AB (publ)'s net margin of -30.18%. Aurora Cannabis' return on equity of 0.59% beat Calliditas Therapeutics AB (publ)'s return on equity.Company Net Margins Return on Equity Return on Assets Calliditas Therapeutics AB (publ)-30.18% -212.04% -27.96% Aurora Cannabis 0.42%0.59%0.42% Which has more risk & volatility, CALT or ACB? Calliditas Therapeutics AB (publ) has a beta of 1.77, suggesting that its share price is 77% more volatile than the S&P 500. Comparatively, Aurora Cannabis has a beta of 1.94, suggesting that its share price is 94% more volatile than the S&P 500. Does the media favor CALT or ACB? In the previous week, Aurora Cannabis had 1 more articles in the media than Calliditas Therapeutics AB (publ). MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Calliditas Therapeutics AB (publ). Aurora Cannabis' average media sentiment score of 0.58 beat Calliditas Therapeutics AB (publ)'s score of 0.00 indicating that Aurora Cannabis is being referred to more favorably in the news media. Company Overall Sentiment Calliditas Therapeutics AB (publ) Neutral Aurora Cannabis Positive Do analysts recommend CALT or ACB? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Calliditas Therapeutics AB (publ) 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aurora Cannabis 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 2 Strong Buy rating(s) 3.67 Do insiders and institutionals hold more shares of CALT or ACB? 2.8% of Calliditas Therapeutics AB (publ) shares are owned by institutional investors. Comparatively, 47.6% of Aurora Cannabis shares are owned by institutional investors. 2.2% of Calliditas Therapeutics AB (publ) shares are owned by insiders. Comparatively, 0.0% of Aurora Cannabis shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. SummaryAurora Cannabis beats Calliditas Therapeutics AB (publ) on 15 of the 18 factors compared between the two stocks. Get Aurora Cannabis News Delivered to You Automatically Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACB vs. The Competition Export to ExcelMetricAurora CannabisMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$309.46M$1.20B$5.48B$8.55BDividend YieldN/AN/A5.26%4.20%P/E Ratio110.1211.7927.1819.93Price / Sales0.9710.48432.85146.63Price / Cash26.3510.4038.2534.64Price / Book0.671.526.824.61Net Income-$48.62M-$54.34M$3.23B$248.05M7 Day Performance-0.09%-0.67%3.42%2.07%1 Month Performance13.95%-1.79%7.11%7.68%1 Year Performance-6.37%-30.68%27.97%11.34% Aurora Cannabis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACBAurora Cannabis0.506 of 5 stars$5.52+2.7%N/A-10.6%$309.46M$320.81M110.121,340CALTCalliditas Therapeutics AB (publ)N/A$40.00flat$39.25-1.9%N/A$1.19B$1.60B-21.62180OCULOcular Therapeutix3.72 of 5 stars$7.30+1.1%$16.25+122.6%+51.2%$1.16B$59.65M-5.53230Analyst RevisionAMPHAmphastar Pharmaceuticals3.7546 of 5 stars$24.47+1.1%$32.33+32.1%-38.4%$1.16B$730.66M8.161,620Positive NewsShort Interest ↑AUPHAurinia Pharmaceuticals3.3119 of 5 stars$8.08-2.3%$11.50+42.3%+49.3%$1.09B$247.30M-53.86300Positive NewsMLYSMineralys Therapeutics2.5607 of 5 stars$15.96-2.2%$38.00+138.1%+23.7%$1.04BN/A-4.3828Positive NewsGap DownRCUSArcus Biosciences2.5122 of 5 stars$9.05+3.0%$25.67+183.8%-36.6%$957.73M$141M-2.87500Short Interest ↑ARDXArdelyx4.6266 of 5 stars$3.97+0.3%$10.39+161.7%-43.2%$949.84M$361.71M-24.8190NTLAIntellia Therapeutics4.6367 of 5 stars$9.16-3.2%$36.90+302.8%-67.3%$948.82M$45.57M-1.68600Analyst ForecastPAHCPhibro Animal Health3.7511 of 5 stars$23.24+1.0%$20.00-13.9%+35.6%$942.01M$1.19B48.421,860Positive NewsCOLLCollegium Pharmaceutical4.1737 of 5 stars$28.86+0.1%$43.80+51.8%-9.4%$927.33M$664.28M12.44210Positive News Related Companies and Tools Related Companies Calliditas Therapeutics AB (publ) Competitors Ocular Therapeutix Competitors Amphastar Pharmaceuticals Competitors Aurinia Pharmaceuticals Competitors Mineralys Therapeutics Competitors Arcus Biosciences Competitors Ardelyx Competitors Intellia Therapeutics Competitors Phibro Animal Health Competitors Collegium Pharmaceutical Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACB) was last updated on 6/4/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredFPV Drone Innovator Secures Major Defense ContractIn May, Ukraine launched Operation Spider Web - a 117-drone FPV swarm that devastated Russian fuel depots and ...The Tomorrow Investor | SponsoredJunior Explorer Taps Into TSMC’s $165 Billion Chip CorridorThe chip war is moving underground. As the U.S. ramps up semiconductor production to outpace China, an unex...Capital Trends | SponsoredThe Recession Already Started, Are You Prepared?Global central banks are stockpiling gold. Billionaires are hedging with precious metals. And thousands of Ame...Lear Capital | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aurora Cannabis Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aurora Cannabis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ACB Stock Free ACB Stock Alerts